181 related articles for article (PubMed ID: 30408112)
1. Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study.
Kuwajima K; Sumitani M; Kurano M; Kano K; Nishikawa M; Uranbileg B; Tsuchida R; Ogata T; Aoki J; Yatomi Y; Yamada Y
PLoS One; 2018; 13(11):e0207310. PubMed ID: 30408112
[TBL] [Abstract][Full Text] [Related]
2. Different Profiles of the Triad of Lysophosphatidylcholine, Lysophosphatidic Acid, and Autotaxin in Patients with Neuropathic Pain Diseases: a Preliminary Observational Study.
Edamura T; Sumitani M; Hayakawa K; Inoue R; Abe H; Tsuchida R; Chikuda H; Ogata T; Kurano M; Aoki J; Yatomi Y; Uchida K
Pain Ther; 2022 Dec; 11(4):1439-1449. PubMed ID: 36205847
[TBL] [Abstract][Full Text] [Related]
3. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain.
Ma L; Uchida H; Nagai J; Inoue M; Aoki J; Ueda H
J Pharmacol Exp Ther; 2010 May; 333(2):540-6. PubMed ID: 20123931
[TBL] [Abstract][Full Text] [Related]
4. Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder.
Itagaki K; Takebayashi M; Abe H; Shibasaki C; Kajitani N; Okada-Tsuchioka M; Hattori K; Yoshida S; Kunugi H; Yamawaki S
Int J Neuropsychopharmacol; 2019 Apr; 22(4):261-269. PubMed ID: 30715387
[TBL] [Abstract][Full Text] [Related]
5. Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia.
Omori W; Kano K; Hattori K; Kajitani N; Okada-Tsuchioka M; Boku S; Kunugi H; Aoki J; Takebayashi M
Int J Neuropsychopharmacol; 2021 Dec; 24(12):948-955. PubMed ID: 34214158
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis.
Hayakawa K; Kurano M; Ohya J; Oichi T; Kano K; Nishikawa M; Uranbileg B; Kuwajima K; Sumitani M; Tanaka S; Aoki J; Yatomi Y; Chikuda H
Sci Rep; 2019 Jun; 9(1):9144. PubMed ID: 31235770
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.
Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H
Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain.
Velasco M; O'Sullivan C; Sheridan GK
Neuropharmacology; 2017 Feb; 113(Pt B):608-617. PubMed ID: 27059127
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain.
Inoue M; Ma L; Aoki J; Ueda H
J Neurochem; 2008 Dec; 107(6):1556-65. PubMed ID: 19014389
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of lysophosphatidylcholine measurement in the cerebrospinal fluid for differential diagnosis of neuropathic pain: Possible introduction into clinical laboratory testing.
Kurano M; Sumitani M; Akiyama Y; Yamada M; Fujimura D; Yamaki S; Kano K; Aoki J; Hayakawa K; Takahashi T; Hirai T; Okawa A; Kume H; Ogata T; Tanaka S; Chikuda H; Yatomi Y
Clin Chim Acta; 2023 Feb; 541():117249. PubMed ID: 36764506
[TBL] [Abstract][Full Text] [Related]
11. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
Okudaira S; Yukiura H; Aoki J
Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
[TBL] [Abstract][Full Text] [Related]
12. Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist.
Ma L; Matsumoto M; Xie W; Inoue M; Ueda H
J Neurochem; 2009 Apr; 109(2):603-10. PubMed ID: 19222705
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
Kremer AE; Martens JJ; Kulik W; Ruëff F; Kuiper EM; van Buuren HR; van Erpecum KJ; Kondrackiene J; Prieto J; Rust C; Geenes VL; Williamson C; Moolenaar WH; Beuers U; Oude Elferink RP
Gastroenterology; 2010 Sep; 139(3):1008-18, 1018.e1. PubMed ID: 20546739
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases.
Gendaszewska-Darmach E
Acta Biochim Pol; 2008; 55(2):227-40. PubMed ID: 18560605
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome.
Kurano M; Suzuki A; Inoue A; Tokuhara Y; Kano K; Matsumoto H; Igarashi K; Ohkawa R; Nakamura K; Dohi T; Miyauchi K; Daida H; Tsukamoto K; Ikeda H; Aoki J; Yatomi Y
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):463-70. PubMed ID: 25425621
[TBL] [Abstract][Full Text] [Related]
16. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
Orosa B; García S; Conde C
Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid provides a missing link between osteoarthritis and joint neuropathic pain.
McDougall JJ; Albacete S; Schuelert N; Mitchell PG; Lin C; Oskins JL; Bui HH; Chambers MG
Osteoarthritis Cartilage; 2017 Jun; 25(6):926-934. PubMed ID: 27651153
[TBL] [Abstract][Full Text] [Related]
18. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of lysophosphatidic acid-induced pain with clinically relevant neuropathic pain drugs.
Ogawa K; Takasu K; Shinohara S; Yoneda Y; Kato A
Eur J Pain; 2012 Aug; 16(7):994-1004. PubMed ID: 22337641
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid and signaling in sensory neurons.
Oude Elferink RP; Bolier R; Beuers UH
Biochim Biophys Acta; 2015 Jan; 1851(1):61-5. PubMed ID: 25218302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
